NHP National Healthcare Properties (NHP) Insider Trading, Ownership & Congress Trades
Real Estate · Real estate investment trusts · CIK 0001561032
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
97
13F, latest reported quarter
National Healthcare Properties insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for National Healthcare Properties, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
no insider purchases or sales on record
0 transactions on record
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
97 funds bought in last quarter
below 62% of Real Estate
Revenue
-3.3% year over year
below 76% of Real Estate
Margin
-16.9% net margin
below 81% of Real Estate
Buybacks
no share repurchases reported
Short interest
12.9% of shares outstanding short · 4.8 days to cover · settled 2026-10-15
more than 94% of Real Estate
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch NHP
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+27.9%12M
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns NHP: institutional holders (13F)
13F holdings, latest reported quarter
8,260,888 sh
$121.0M
4,927,274 sh
$72.2M
4,893,792 sh
$71.7M
4,504,336 sh
$66.0M
3,838,482 sh
$56.2M
Congress trades in NHP
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
NHP planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
NHP mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
PGIM Real Estate Income Fund
$1.2M position · as of 2026-07-31
2.0%
Easterly Global Real Estate Fund
$3.1M position · as of 2026-05-31
1.7%
PGIM US Real Estate Fund
$5.8M position · as of 2026-06-30
1.5%
Dunham Real Estate Stock Fund
$1.1M position · as of 2026-07-31
1.4%
PGIM Select Real Estate Fund
$3.7M position · as of 2026-07-31
1.4%
AB Global Real Estate Investment Fund II
$2.5M position · as of 2026-07-31
1.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Edward M. Weil, Jr.
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$154.4K
$154.4K
$420.2K
n/a
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. This filer reported no return figures.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 97 funds added last quarter. Each figure is a federal filing, dated the day it went public.
NHP financials
Revenue growth
-3.3%
XBRL, annual
Net margin
-16.9%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$344.3M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM NHP
| FY Dec 2025 | $342.3M |
| FY Dec 2024 | $353.8M |
| FY Dec 2023 | $345.9M |
| FY Dec 2022 | $335.8M |
| FY Dec 2021 | $329.4M |
| Jun 2026 | $87.5M |
| Mar 2026 | $86.3M |
| Dec 2025 | $84.5M |
| Sep 2025 | $86.0M |
| Jun 2025 | $85.3M |
| Mar 2025 | $86.4M |
| Dec 2024 | $87.7M |
| Sep 2024 | $88.9M |
At each fiscal year end
Single quarter
Net margin, TTM
-13.1%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM NHP
| FY Dec 2025 | -16.9% |
| FY Dec 2024 | -53.8% |
| FY Dec 2023 | -20.9% |
| FY Dec 2022 | -23.7% |
| FY Dec 2021 | -25.9% |
| Jun 2026 | -6.2% |
| Mar 2026 | -5.0% |
| Dec 2025 | -27.0% |
| Sep 2025 | -14.6% |
| Jun 2025 | -24.4% |
| Mar 2025 | -1.8% |
| Dec 2024 | -19.4% |
| Sep 2024 | -45.8% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$23.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM NHP
| FY Dec 2025 | -$21.8M |
| FY Dec 2024 | -$101.8M |
| FY Dec 2023 | -$773.0K |
| FY Dec 2022 | $302.0K |
| FY Dec 2021 | $19.8M |
| Jun 2026 | $16.3M |
| Mar 2026 | $3.7M |
| Dec 2025 | -$1.8M |
| Sep 2025 | $5.6M |
| Jun 2025 | $1.4M |
| Mar 2025 | -$26.9M |
| Dec 2024 | $946.0K |
| Sep 2024 | -$100.5M |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity NHP
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt NHP
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-5.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity NHP
| FY Dec 2025 | -9.0% |
| FY Dec 2024 | -24.1% |
| FY Dec 2023 | -7.7% |
| FY Dec 2022 | -7.9% |
| FY Dec 2021 | -8.6% |
| Jun 2026 | -5.3% |
| Mar 2026 | -9.5% |
| Dec 2025 | -9.0% |
| Sep 2025 | -7.8% |
| Jun 2025 | -11.4% |
| Mar 2025 | -22.7% |
| Dec 2024 | -24.1% |
| Sep 2024 | -24.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-2.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets NHP
| FY Dec 2025 | -3.2% |
| FY Dec 2024 | -9.3% |
| FY Dec 2023 | -3.3% |
| FY Dec 2022 | -3.6% |
| FY Dec 2021 | -3.8% |
| Jun 2026 | -2.4% |
| Mar 2026 | -3.4% |
| Dec 2025 | -3.2% |
| Sep 2025 | -2.8% |
| Jun 2025 | -4.1% |
| Mar 2025 | -8.9% |
| Dec 2024 | -9.3% |
| Sep 2024 | -9.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital NHP
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
assets or current liabilities not filed
Return on capital employed NHP
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing NHP
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value NHP
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.5%
TTM free cash flow over market value at close 2026-10-26
FCF yield NHP
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | +5.7% |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing NHP
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $342.3M | $353.8M | $345.9M | $335.8M |
| Gross profit | $123.4M | $132.3M | $128.1M | $122.4M |
| Operating income | $3.3M | -$123.5M | -$4.7M | -$31.5M |
| Net income | -$57.7M | -$190.3M | -$72.4M | -$79.6M |
| EPS (diluted) | -2.51 | -7.19 | -3.04 | -3.30 |
| Operating cash flow | $7.0M | -$79.8M | $21.6M | $28.3M |
| Cash | $57.6M | $21.7M | $46.4M | $53.7M |
| Buybacks | n/a | n/a | n/a | $0 |
| Dividends paid | n/a | n/a | n/a | $0 |
SEC XBRL, fiscal years, as known on 2026-10-28
NHP Stock Sonar score 4/7 axes
Find similar shapesCompareNHP ranks highest on institutional and government (38th percentile) and growth (24th), and lowest on risk and compliance (10th), among Real Estate peers.
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
